AKEBIA THERAPEUTICS, INC. Accrued Income Taxes, Current
AKEBIA THERAPEUTICS, INC. (AKBA) had Accrued Income Taxes, Current of $987.00 thousand as of 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2019-03-26
- 2018-03-31: Accrued Income Taxes, Current $987.00K.
- 2017-12-31: Accrued Income Taxes, Current $987.00K.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2018-03-31 | $987.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $987.00K 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |